OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The latest news and technology advances for drug dosage forms.
Fatty alcohols may enhance the skin permeation of clotrimazole.
The right partner can help companies overcome key formulation challenges.
Plasma-based proteins and cell-based therapies can address unmet medical needs.
February 23, 2021
Aprecia's compression-free 3DP manufacturing platform and Glatt’s multiparticulate technologies offer solutions to pharmaceutical dosage design challenges.
February 17, 2021
The EC has granted marketing authorization to Celltrion Healthcare for its adalimumab biosimilar, Yuflyma (CT-P17).
February 03, 2021
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving development of innovative delivery solutions.
Advanced manufacturing technologies are available, but challenges need to be addressed.
February 02, 2021
The EC intends to get tougher on issues such as reliability of drug supplies, particularly essential medicines.
February 01, 2021
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
January 29, 2021
The dispute between the European Commission (EC) of the European Union and pharmaceutical company AstraZeneca continues.
Although a necessity, companies must strike a critical balance between protecting innovations with IP and providing affordable access to medicines.
January 07, 2021
Intravacc and Cristal Therapeutics have entered into a strategic collaboration for the development of novel vaccine programs against human diseases.
January 05, 2021
Amid pressure to get more vaccines administered faster, FDA pushes back against changes in dosing regimens.
January 03, 2021
FDA approval rate speeds up despite COVID-19 complications.
The right partner can help companies overcome key formulation challenges for biologic drugs.
January 02, 2021
Shutting down the COVID-19 pandemic requires a global, selfless effort.
December 31, 2020
Administration of the COVID-19 vaccination from Oxford University and AstraZeneca is expected to begin in the UK in early 2021.
December 21, 2020
Moderna’s mRNA vaccine to prevent COVID-19 disease is granted FDA Emergency Use Authorization and CDC recommendation.
A decision by the European Commission on conditional marketing authorization for the European Union’s first COVID-19 vaccine is expected soon.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
December 11, 2020
Committee recommends Emergency Use Authorization of first mRNA-based COVID-19 vaccine; FDA approval is pending.
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 08, 2020
A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.